IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Flagship Pioneering, LLC

Q3 2019 Holdings

Filed 2019-11-14 | 20 holdings | $1.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Moderna Inc(MRNA)COM60770K107$936.2K58,807,37951.2%
Rubius Therapeutics IncCOM78116T103$300.6K38,296,52616.4%
Kaleido Biosciences Inc(KLDO)COM483347100$130.7K17,360,7107.2%
Denali Therapeutics Inc(DNLI)COM24823R105$122.6K8,005,7476.7%
Evelo Biosciences IncCOM299734103$111.2K18,233,4036.1%
Seres Therapeutics Inc(MCRB1EUR)COM81750R102$86.5K21,571,7644.7%
TransMedics Group Inc(TMDX)COM89377M109$60.1K2,530,2753.3%
Axcella Health IncCOM05454B105$49.5K8,748,4142.7%
Syros Pharmaceuticals IncCOM87184Q107$30.5K2,938,4941.7%
Quanterix Corp(QTRX)COM74766Q101$000.0%